• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Leveraged buyout costs hit yearlong high

Leveraged buyout costs hit yearlong high

August 16, 2011 By MassDevice staff

MassDevice.com Funding Roundup

Leveraged buyouts, like the $6.3 billion deal to take Kinetic Concepts Inc (NYSE:KCI) private, are as expensive as they’ve been all year, due to ongoing uncertainty about the global economy.

Average monthly interest rates on institutional leveraged loans, the debt used to finance LBOs, rose to 491 basis points more than benchmarks in July, according to Bloomberg News – up from a February low of 378 basis points.

The upshot for would-be LBO dealmakers is an extra $11.3 million in annual interest for every $1 billion borrowed, adding nearly $71.2 million to Apax Partner’s LLP’s nut for the KCI deal.

Apax has already landed commitments for the deal representing a healthy percentage of the $10.3 billion banks have agreed to shell out to finance some $14 billion worth of buyouts, according to the news service. It’s the biggest deal of its stripe since Lehman Brothers Holdings Inc. folded up its tents in September 2008. New York-based private equity player Apax plans to fund the buyout with $4.95 billion in loans and bonds, including $2.15 billion of notes and a $2.6 billion term loan.

In another health care LBO, Blackstone Group LP plans to back its $3 billion acquisition of Emdeon Inc. with a $1.2 billion term loan and up to $750 million in notes, according to Bloomberg. Bank of America Corp., Barclays Plc and Citigroup Inc. agreed to pony up a $750 million bridge loan to cover the balance not covered by the note offering and a $125 million revolving credit line for Emdeon.

And TPG Capital is funding its $1.97 billion buyout of blood screening company Immucor Inc. with a $600 million “covenant-lite” term loan – meaning less protection for lenders than traditional bank debt, according to the news service – and $400 million in senior notes.

Filed Under: Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Apax Partners, Emdeon Inc., Immucor Inc., Kinetic Concepts Inc., The Blackstone Group LP, TPG Capital, Venture Capital/Private Equity

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy